Growth Metrics

Cytosorbents (CTSO) Operating Margin (2011 - 2026)

Cytosorbents posted quarterly Operating Margin of 34.34% for Q1 2026, up 1021.0% year-on-year from 3.06% in Q1 2025, and up 27.68% on a QoQ basis from 47.49% in Q4 2025.

Cytosorbents (CTSO) has 16 years of Operating Margin data on file, last reported at 34.34% in Q1 2026.

  • For the quarter ending Q1 2026, Operating Margin rose 1021.0% year-over-year to 34.34%; the trailing twelve-month figure through Mar 2026 stood at 37.38% (up 700.0% YoY), and the FY2025 full-year result was 39.79%, up 643.0% from the prior year.
  • Operating Margin for Q1 2026 stood at 34.34%, up from 47.49% in the prior quarter.
  • Across five years, Operating Margin topped out at 30.17% in Q3 2025 and bottomed at 111.17% in Q3 2022.
  • The 5-year median for Operating Margin is 56.08% (2024), against an average of 64.2%.
  • The widest annual swing landed in 2022, when Operating Margin slumped 6273 bps; it then soared 7144 bps in 2024.
  • A 5-year view of Operating Margin shows it stood at 67.69% in 2022, then plunged by 60 bps to 108.54% in 2023, then surged by 66 bps to 37.1% in 2024, then retreated by 28 bps to 47.49% in 2025, then advanced by 28 bps to 34.34% in 2026.
  • The last three Operating Margin figures came in at 34.34% (Q1 2026), 47.49% (Q4 2025), and 30.17% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.17%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -34.34%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -34.34%
Dec 31, 2025 -47.49%
Sep 30, 2025 -30.17%
Jun 30, 2025 -37.59%
Mar 31, 2025 -44.55%
Dec 31, 2024 -37.10%
Sep 30, 2024 -56.08%
Jun 30, 2024 -40.38%
Mar 31, 2024 -51.80%
Dec 31, 2023 -108.54%
Sep 30, 2023 -83.42%
Jun 30, 2023 -69.62%
Mar 31, 2023 -83.51%
Dec 31, 2022 -67.69%
Sep 30, 2022 -111.17%
Jun 30, 2022 -98.37%
Mar 31, 2022 -89.64%
Dec 31, 2021 -88.68%
Sep 30, 2021 -55.39%
Jun 30, 2021 -40.96%
Mar 31, 2021 -26.91%
Dec 31, 2020 -22.03%
Sep 30, 2020 -18.58%
Jun 30, 2020 -33.67%
Mar 31, 2020 -28.47%
Dec 31, 2019 -73.10%
Sep 30, 2019 -92.33%
Jun 30, 2019 -58.24%
Mar 31, 2019 -82.54%
Dec 31, 2018 -91.85%
Sep 30, 2018 -47.20%
Jun 30, 2018 -72.76%
Mar 31, 2018 -62.97%
Dec 31, 2017 -81.89%
Sep 30, 2017 -56.19%
Jun 30, 2017 -65.36%
Mar 31, 2017 -50.02%
Dec 31, 2016 -148.22%
Sep 30, 2016 -88.91%
Jun 30, 2016 -120.93%
Mar 31, 2016 -115.46%
Dec 31, 2015 -125.74%
Sep 30, 2015 -160.04%
Jun 30, 2015 -231.08%
Mar 31, 2015 -375.01%
Dec 31, 2014 -330.99%
Sep 30, 2014 -127.63%
Jun 30, 2014 -133.06%
Mar 31, 2014 -108.66%
Dec 31, 2013 -52.44%
Sep 30, 2013 -129.94%
Jun 30, 2013 -1,099.36%
Mar 31, 2013 -807.64%
Dec 31, 2012 -924.20%
Sep 30, 2012 -4,394.90%
Jun 30, 2012 -2,019.01%
Mar 31, 2012 -2,124.85%
Dec 31, 2011 -2,684.27%